NL-OMON35932招募中4 期
Diarrhea during use of the oral angiogenesis inhibitors sunitinib and sorafenib - Diarrhea during use of sunitinib and sorafenib
Integraal Kankercentrum Oost0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with renal cell carcinoma, GIST, hepatocellular carcinoma or medullary thyroid carcinoma treated with sunitinib or sorafenib
- •Diarrhea CTC grade >= 1, generated during the use of angiogenesis inhibitor
- •Age >= 18 years
- •Signed informed consent
排除标准
- •Known history of relevant disorders: absorption disorders such as inflammatory bowel disease, celiac disease or lactose intolerance
- •Use of laxatives
研究者
相似试验
招募中
不适用
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina
已完成
不适用
The effects of orally and intraduodenally administered pea protein on satiety parameters in vivo in lean and obese subjects.Obesitasoverweight10003018NL-OMON34022niversiteit Maastricht24
进行中（未招募）
不适用
Intravenous and oral rehydration of children with severe malnutrition and gastroenteritisISRCTN76149273Imperial College, London336
已完成
不适用
Efficacy of oral intra-dialysis supplement in haemodialysis patients with malnutritioISRCTN11132850Foundation of Metabolic Studies (Fundacion de estudios metabolicos) (Spain)80
招募中
不适用
Effect of enteral protein supplements on malnourished hemodialysis patientsKidney DiseasePACTR202209728463176Mariam Shaker Nazeh70